Sa La Kim
Affiliations: | 2017-2019 | Biology | California State University, Northridge, Los Angeles, CA, United States |
Google:
"Sa Kim"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kim GB, Kim S, Hwang YH, et al. (2023) Harnessing Oncolytic Extracellular Vesicles for Tumor Cell-Preferential Cytoplasmic Delivery of Misfolded Proteins for Cancer Immunotherapy. Small (Weinheim An Der Bergstrasse, Germany). e2300527 |
| Kim S, Kim SA, Han J, et al. (2021) Rho-Kinase as a Target for Cancer Therapy and Its Immunotherapeutic Potential. International Journal of Molecular Sciences. 22 |
| Nam GH, Kwon M, Jung H, et al. (2021) Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer. Journal For Immunotherapy of Cancer. 9 |
| You D, Jeong Y, Yoon SY, et al. (2021) Entelon ( Seed Extract) Prevents Cancer Metastasis via the Downregulation of Interleukin-1 Alpha in Triple-Negative Breast Cancer Cells. Molecules (Basel, Switzerland). 26 |
| Kim S, You D, Jeong Y, et al. (2021) Inhibition of platelet-derived growth factor receptor synergistically increases the pharmacological effect of tamoxifen in estrogen receptor α positive breast cancer. Oncology Letters. 21: 294 |
| Kim S, You D, Jeong Y, et al. (2021) Inhibition of platelet-derived growth factor C and their receptors additionally increases doxorubicin effects in triple-negative breast cancer cells. European Journal of Pharmacology. 173868 |
| Cho JH, Kim K, Kim SA, et al. (2020) Deubiquitinase OTUD5 is a positive regulator of mTORC1 and mTORC2 signaling pathways. Cell Death and Differentiation |
| Nam GH, Choi Y, Kim GB, et al. (2020) Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy. Advanced Materials (Deerfield Beach, Fla.). e2002440 |
| Liu R, Choi HS, Kim SL, et al. (2020) 6-Methoxymellein Isolated from Carrot ( L.) Targets Breast Cancer Stem Cells by Regulating NF-κB Signaling. Molecules (Basel, Switzerland). 25 |
| Kim SL, La MT, Shin MW, et al. (2020) A novel HDAC1 inhibitor, CBUD‑1001, exerts anticancer effects by modulating the apoptosis and EMT of colorectal cancer cells. International Journal of Oncology |